Orexo
Develops pharmaceuticals and digital therapies for substance use and mental health.
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Manufacturing
Description
Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-08-29 11:07 | English | 34.3 KB | |||
| 2013-08-28 10:30 |
Orexo reports successful completion of OX51 phase II dose-finding study in prev…
|
English | 31.5 KB | ||
| 2013-08-28 10:30 |
Orexo meddelar att OX51 fas II-studie för förebyggande av smärta i samband med …
|
Swedish | 34.4 KB | ||
| 2013-08-26 08:00 |
Orexo AB konverterar konvertibellån från Novo A/S
|
Swedish | 27.7 KB | ||
| 2013-08-26 08:00 |
Orexo AB converts convertible bonds subscribed for by Novo A/S
|
English | 27.7 KB | ||
| 2013-08-07 08:15 |
First patient dosed in new study on long-term adherence to treatment of opioid …
|
English | 32.9 KB | ||
| 2013-08-07 08:15 |
Första patienten har påbörjat medicineringen i en ny klinisk studie syftande ti…
|
Swedish | 32.6 KB | ||
| 2013-08-06 16:45 |
Kommuniké från extra bolagsstämma i Orexo AB den 6 augusti 2013
|
Swedish | 162.4 KB | ||
| 2013-08-06 16:45 |
Report from the extraordinary general meeting in Orexo AB, 6 August 2013
|
English | 185.3 KB | ||
| 2013-07-19 08:00 |
Letter to shareholders from Chairman Martin Nicklasson
|
English | 162.5 KB | ||
| 2013-07-19 08:00 |
Aktieägarbrev från ordförande Martin Nicklasson
|
Swedish | 89.2 KB | ||
| 2013-07-15 08:55 |
Orexo appoints Henrik Juuel as new CFO
|
English | 166.6 KB | ||
| 2013-07-15 08:55 |
Orexo utser Henrik Juuel till ny CFO
|
Swedish | 92.2 KB | ||
| 2013-07-12 08:00 | Swedish | 1.1 MB | |||
| 2013-07-12 08:00 | English | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orexo
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orexo via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
